High and low tumor PD-L1 H score (prevalence: both 26%) showed correlation with complete response and progression, respectively; H score was calculated by multiplying the% of PD-L1+ malignant cells [by double staining with anti-PD-L1 (405.9A11) and anti-PAX5 mAbs] by the average intensity of positive staining (1, 2, or 3+). This evidence concerns the gene PAX5 and neoplasm.